HGHSX Mutual Fund

NAV$46.13

Fund Essentials - as of Jan 31, 2026

Net Assets
$9M
Expense Ratio
1.31%
Dividend Yield (Current)
3.05%
Holdings
84
Inception Date
Dec 22, 2006
Fund Family
Hartford Funds
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+5.20%
1 Year+32.43%
3 Year+8.58%
5 Year+5.20%
10 Year+13.06%

Asset Allocation

Stocks: 99.68%
Bonds: 0.19%
Cash: 0.14%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co13.12%
MRKMerck & Company Inc5.74%
JNJJohnson & Johnson5.07%
UNHUnitedhealth Group Incorporated4.64%
ABBVAbbvie Inc3.84%
Top 10 Concentration: 47.48%Report Date: Jan 31, 2026
Download all 84 holdings for HGHSX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.05%
Frequency
Annually
Latest Distribution
$4.37
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

HGHSX Mutual Fund Overview

HGHSX Mutual Fund (The Hartford Healthcare Fund Cl R4) is managed by Hartford Funds with $8.5M in net assets. HGHSX expense ratio is 1.31%, holding 84 positions across sectors including Health Care, Unknown, Financials. Inception date: 2006-12-22.

HGHSX performance shows a YTD return of 5.20%. The 1-year return is 32.43% and the 5-year return is 5.20%. HGHSX dividend yield stands at 3.05%, paid annually.

HGHSX top holdings include Eli Lilly & Co (13.1%), Merck & Company Inc (5.7%), Johnson & Johnson (5.1%), Unitedhealth Group Incorporated (4.6%), Abbvie Inc (3.8%). View all HGHSX holdings, sector breakdown, or dividend history.

HGHSX can be compared against other funds using the overlap calculator or side-by-side comparison tool. HGHSX alternatives are available via the screener, along with tax-loss harvesting opportunities.